2019 International Congress Archives - Page 42 of 217

Laboratory Performance of the DopaFuse® Delivery System

R. Draper, J. Harmon, A. Heller, B. Heller, E. Heller, C. King, T. Lau, P. Plante, J. Spiridigliozzi (Austin, TX, USA)
Lack of Notable Skin Reactions from a Novel Levodopa/Carbidopa Prodrug after 10 Days of Repeated 24-Hour Continuous Subcutaneous Infusion at the Same Administration Site

M. Facheris, X. Qi, C. Locke, M. Rosebraugh, J. Benesh (North Chicago, IL, USA)
Language characteristics of picture description task by Hebrew speaking patients with Parkinson’s disease

D. Shpunt, S. Naor, N. Diamant, A. Faust-Socher, H. Shabtai, R. Peled, A. Migirov, T. Gurevich, Y. Manor (Tel Aviv, Israel)
Language disorders in Progressive Supranuclear Palsy: an underestimated condition?

E. Del Prete, L. Tommasini, D. Frosini, S. Mazzucchi, C. Pagni, U. Bonuccelli, R. Ceravolo (Pisa, Italy)
Large Sample Study on Paroxysmal Kinesigenic Dyskinesia: Genotype-Phenotype Analysis and Diagnosis Recommendations

L. Cao, XJ. Huang, SG. Wang, WT. Tian, HD. Tang, JY. Shen, C. Zhang, ZY. Zhu, FX. Zhan, XQ. Che, SD. Chen, XL. Liu, T. Wang, YQ. Xu, HW. Gui, L. Zheng, L. Wu, TY. Rong, M. Zhang, Y. Wang, GH. Bi, WG. Tang, BS. Tang, XM. Yin, X. Mao, S. Zeng, JL. Wang, J. Li, Q. Liu, XN. Guo, CY. Wang, W. Lu, RX. Zhang, XR. Liu, Y. Zhang, ZG. Liu, GH. Zhao (Shanghai, China)
Late onset idiopathic cerebral edema associated with deep brain stimulation

M. Blázquez Estrada, P. Siso García, E. Suárez Sanmartín, J. Sol Alvarez, E. Santamarta Liébana, C. García Fernández, B. Lozano Aragoneses, J. Alvarez Carriles, A. Sáiz Ayala (Oviedo, Spain)
LATE ONSET OF PARKINSON’S DISEASE

I. Smolentseva, N. Amosova, A. Kuzmina (Moscow, Russian Federation)
Left STN DBS And Right CZI DBS In A Patient With Tremor-Predominant Parkinson’s Disease

T. Ali, D. Ginjupally, G. Quintero, C. van Horne, Z. Guduru (Lexington, KY, USA)
Levocarb-induced diplopia in idiopathic Parkinson’s disease: a case report

S. Joza, F. Ba (Edmonton, AB, Canada)
Levodopa Effects on Visuospatial Working Memory in Parkinson’s Disease

E. Bayram, I. Litvan, B. Wright, C. Grembowski, D. Harrington (La Jolla, CA, USA)
Levodopa Induced dyskinesia in patients with Parkinson’s disease and polymorphisms gene DRD3 dopamine receptor

I. Zhukova, N. Zhukova, E. Kolupaeva, S. Ivanova, M. Nikitina, O. Izhboldina, I. Mironova (Tomsk, Russian Federation)
Levodopa response in later stages of Parkinson’s disease: a case-control study

M. Fabbri, M. Coelho, D. Abreu, L. Guedes, M. Rosa, A. Antonini, J. Ferreira (Lisbon, Portugal)
Levodopa-carbidopa intestinal gel infusion: a video analysis of long-term effect on gait and posture

C. Pongmala, M. Fabbri, CA. Artusi, M. Zibetti, L. Lopiano (Turin, Italy)
Levodopa-responsive tremor in a young child as a delayed complication of osmotic demyelination from severe hypernatremia

L. Tochen, M. Cameron, C. Brady, M. Fleming (Washington, DC, USA)
Levodopa/carbidopa Intestinal Gel in Treatment of Non-Motor Symptoms in Advanced Parkinson’s Disease

W. Kamel, J. Al Hashel (Beni Suef, Egypt)
Life expectancy with and without Parkinson’s disease in the general population

L. Dommershuijsen, A.. Ikram, K. Ikram (Rotterdam, Netherlands)
Limitations of Curcumin as a Therapeutic Agent in Rotenone Induced Dopaminergic Neurodegeneration: Insights from Drosophila Model of Parkinson’s Disease

M. Ayajuddin, SC. Yenisetti (Zunheboto, India)
Lip movement contribution in speech production of persons with Parkinson’s Disease

P. Upadhyay, S. Gudwani, K. Sharma, R. Sagar, R. Dhamija, S. Kumaran (New Delhi, India)
Liquid Levodopa/Carbidopa – An underutilized, cost effective treatment of advanced Parkinson’s disease in the developing world

A. Panwar, N. Sawal (Chandigarh, India)
Local anesthesia vs general anesthesia in STN-dDBS operation: a clinical comparison of the outcome of patients with advanced Parkinson’s disease

M. Koivu, J. Resendiz-Nieves, J. Eerola-Rautio, F. Scheperjans, R. Kivisaari, E. Pekkonen (Helsinki, Finland)
Local beta band synchronization predicts clinically-selected deep brain stimulation contact in Parkinson’s disease patients

W. Lipski, HJ. Park, A. Jorge, A. Kent, Y. Pathak, RM. Richardson (Pittsburgh, PA, USA)
Local field potential recordings in the human pallidum using externalized directional DBS leads

L. Johnson, J. Aman, D. Escobar Sanabria, J. Wang, R. Patriat, M. Petrucci, M. Hill, G. Molnar, S. Cooper, L. Schrock, C. Mackinnon, N. Harel, M. Park, J. Vitek (Minneapolis, MN, USA)
Long term evolution of ventilatory function in Parkinson’s disease

G. Baille, C. Chenivesse, T. Perez, D. Devos, L. Defebvre, C. Moreau (Lille, France)
Long Term Follow Up Following Multidisciplinary Inpatient Rehabilitation for Functional Movement Disorders

A. Kompoliti, C. Hebert, J. Behel, G. Pal, R. Kasi (Chicago, IL, USA)
Long term outcome of STN-DBS for Parkinson Disease patients using Directional mode setting programs

K. Kimura, H. Kishida, T. Kawasaki, N. Ueda, F. Tanaka (Yokohama, Japan)
Long-term adherence with wearing a multi-sensor watch in the Personalized Parkinson Project

L. Evers, R. Kapur, T. V.D. Zande, M. Meinders, B. Bloem, W. Marks, JR. (Nijmegen, Netherlands)
Long-term apomorphine infusion (APO) users versus short-term APO users: What is the reason to discontinue therapy? A multi-centre study

R. Bhidayasiri, O. Phokaewvarangkul, K. Boonpang, Y. Thongchuam, T. Boonmongkol, P. Garcia Ruiz (Bangkok, Thailand)
Long-term changes in myocardial sympathetic innervation and function in synucleinopathies

G. Lamotte, C. Holmes, T. Wu, D. Goldstein (Bethesda, MD, USA)
Long-term effect of levodopa-carbidopa intestinal gel on axial signs in Parkinson’s disease

M. Fabbri, P. Chatkaew, C. Artusi, A. Romagnolo, M. Rizzone, M. Zibetti, L. Lopiano (Turin, Italy)
Long-term effects of bilateral subthalamic nucleus stimulation on sleep in patients with Parkinson’s disease

J. Choi, H. Kim, D. Yoo, J. Im, S. Paek, B. Jeon (Seoul, Republic of Korea)
Long-Term Effects of LPS and Alcohol in Rats: A Model of Neuro-Degenerative Disease

M. Schiess, M. Doursout, J. Campo, Z. Peng, A. Sundaresan, S. Umar (Lawrence, KS, USA)
Long-term follow up of unilateral focused ultrasound subthalamotomy for the treatment of motor features in asymmetric PD

J. Máñez-Miró, R. Martinez-Fernandez, M. Del álamo, F. Hernandez-Fernandez, R. Rodríguez-Rojas, J. Pineda-Pardo, F. Alonso-Frech, L. Vela-Desojo, J. Obeso (Móstoles-Madrid, Spain)
Long-term impact of Levodopa Carbidopa Intestinal Gel (LCIG) on reducing “Off” time: Results from a systematic review of studies with ≥ 12 months of follow-up

A. Antonini, P. Odin, R. Pahwa, J. Aldred, A. Alobaidi, Y. Jalundhwala, P. Kukreja, L. Bergmann, S. Inguva, Y. Bao, K. Chaudhuri (North Chicago, IL, USA)
Long-term levodopa-carbidopa intestinal infusion in Parkinson’s disease: survival and mortality

CA. Artusi, R. Balestrino, G. Imbalzano, S. Bortolani, S. Tuttobene, E. Montanaro, M. Zibetti, L. Lopiano (Torino, Italy)
Long-term Motor and Non-motor Outcomes in Parkinson’s Disease Following Deep Brain Stimulation

D. Isaacs, T. Davis, F. Phibbs, J. Fang, A. Nagy, H. Koons, T. Hassell, P. Konrad, H. Yu, P. Hedera (Nashville, TN, USA)
Long-Term Outcomes in Patients with Tardive Dyskinesia who Were Early Responders with Valbenazine

S. Factor, C. Comella, S. Marder, J. Burke, K. Farahmand, S. Siegert (Atlanta, GA, USA)
Long-Term Outcomes with Valbenazine 40 mg/day in Adults with Tardive Dyskinesia

S. Marder, C. Comella, C. Singer, C. Chepke, J. Burke, K. Farahmand, S. Siegert (Los Angeles, CA, USA)
Long-term safety and efficacy of apomorphine infusion in Parkinson’s disease (PD) patients with persistent motor fluctuations: results of the 1-year open-label phase of the TOLEDO study

R. Katzenschlager, W. Poewe, O. Rascol, C. Trenkwalder, G. Deuschl, K. Chaudhuri, T. Henriksen, T. van Laar, D. Lockhart, A. Lees (London, United Kingdom)
Long-term safety and efficacy of rimabotulinumtoxinB in the treatment of adult sialorrhea

K. Dashtipour, S. Isaacson, M. Lew, D. Chary, T. Clinch, R. Pahwa (Boca Raton, FL, USA)
Long-term treatment of cervical dystonia with abobotulinumtoxinA

A. Jochim, T. Meindl, T. Mantel, S. Zwirner, F. Castrop, B. Haslinger (Munich, Germany)
Long-Term Treatment With Deutetrabenazine Is Associated With Continued Improvement in Tardive Dyskinesia: Results From an Open-Label Extension Study

R. Hauser, H. Barkay, H. Fernandez, S. Factor, J. Jimenez-Shahed, N. Gross, M. Gordon, JM. Savola, K. Anderson (Tampa, FL, USA)
Long-term Yearly Trends of Feeding Tube Placement in Neurodegenerative Disorders

D. Kim, R. Jones, A. D'Abreu, J. Friedman, U. Akbar (Providence, RI, USA)
Longitudinal analysis of disease progression in a large PKAN cohort in the Dominican Republic

C. Muniz, S. Baser, R. Ericson, M. Santana Jimenez, C. Bass, F. Middleton (Santo Domingo, Dominican Republic)
Longitudinal Analysis of the Corticospinal tract microstructure in Parkinson’s Disease Patients

R. Guimarães, L. Piovesana, P. Azevedo, B. Campos, F. Cendes (Campinas, Brazil)
Longitudinal analysis of the modified Hoehn and Yahr disease stage in PD-1101, a Phase 1b clinical study of VY-AADC01

A. van Laar, R. Richardson, A. Sedkov, E. Fine, K. Bankiewicz, B. Ravina, P. Larson, C. Christine (Pittsburgh, PA, USA)
Longitudinal analysis of the relation between trajectories of dopaminergic agonists use and BMI in Parkinson’s disease

F. Artaud, PC. Lee, M. Vidailhet, JC. Corvol, A. Elbaz (Saint-Aubin, France)
Longitudinal assessment of genetic determinants of cognitive decline in Parkinson’s disease

M. Bakeberg, A. Jefferson, M. Byrnes, S. Ghosh, F. Mastaglia, R. Stell, J. Kenna, S. Walters, M. Hoes, A. Ford, R. Anderton (Nedlands, Australia)
Longitudinal Change of Substantia Nigra Hyperechogenicity in Parkinson’s Disease Cohort

T. Toomsoo, I. Rubanovits, R. Kerner, T. Asser, M. Vähi, P. Taba (Tallinn, Estonia)
Longitudinal Cortical Changes Associated with Apathy in Parkinson’s Disease

E. Canu, F. Agosta, F. Imperiale, T. Stojković, I. Stankovic, S. Basaia, A. Fontana, V. Markovic, I. Petrović, E. Stefanova, V. Kostic, M. Filippi (Milan, Italy)
Longitudinal CSF-profile and brain pathology mirrors clinical course of LRRK2-Related Parkinson’s Disease

I. Wurster, S. Lerche, I. Lachmann, M. Neumann, T. Gasser, K. Brockmann (Tübingen, Germany)
Longitudinal digital observation of the holistic quality of the life of patients with Parkinson’s disease

F. Thieken, A. Greuel, L. Timmermann, K. Sohrabi, C. Woopen, B. Schmitz-Luhn, A. Janhsen, C. Eggers (Marburg, Germany)
Longitudinal DNA methylation changes, in blood, associated with Parkinson’s disease progression

A. Henderson, K. Fisch, J. Hua, E. Driver-Dunckley, C. Sherzer, P. Desplats, T. Dunckley (Tempe, AZ, USA)
Longitudinal progression of spatiotemporal parameters of turning in idiopathic Parkinson’s disease patients with Freezing of Gait

L. Pillai, A. Glover, T. Virmani (Little Rock, AR, USA)
Longstanding cervical dystonia followed by parkinsonism – coincidence, risk factor or syndromic association?

B. Balint, F. Gövert, A. Latorre, E. Mulroy, R. Erro, A. Batla, T. Warner, K. Bhatia (London, United Kingdom)
Looking “cherry red spot myoclonus” in the eyes

GM. Riboldi, J. Martone, JR. Rizzo, T. Hudson, S. Frucht, J. Rucker (New York, NY, USA)
Low and high beta band activity in the primary sensorimotor cortex is diminished by ipsilateral subthalamic stimulation in Parkinsonian patients

G. Tamas, A. Kelemen, B. Javor-Duray, M. Palotai, L. Halasz, L. Eross, G. Fekete, L. Bognar, G. Deuschl, M. Muthuraman (Budapest, Hungary)
Low doses of scopolamine exacerbates dementia among Drosophila with Parkinson’s disease pathophysiology

G. Chandran (Mysore, India)
Lower urinary tract symptoms and urodynamic findings in SCAs

M. Jang, H. Kim, B. Jeon, A. Kim (Jeonju, Republic of Korea)
LRP10 variants and Parkinson’s disease in the Chinese population

JN. Foo, E. Chew, M. Lian, M. Tandiono, EK. Tan (Singapore, Singapore)
LY-341,495, an mGlu2/3 antagonist, abolishes the anti-dyskinetic and anti-psychotic effects of the mGlu2/3 orthosteric agonist LY-354,740 in the MPTP-lesioned marmoset

A. Hamadjida, S. Nuara, J. Gourdon, P. Huot (Montreal, QC, Canada)
Lymphocyte Senescence in Parkinson’s Disease

M. Jensen, K. Scott, M. Camacho, A. Kouli, R. Wijeyekoon, I. Solim, R. Barker, C. Williams-Gray (Cambridge, United Kingdom)